Bull looks for Alkermes to bounce

By
A A A

The bears have driven Alkermes to a key support level, and now one investor is positioning for a rebound.

ALKS ALKS rose 3.13 percent to $11.22 in afternoon trading. The drug-delivery stock is down 20 percent since March 15, when it gapped higher on optimism about the Bydureon diabetes treatment. Two months later, it plunged on a weak earnings report and has been trapped below $12 since.

Today's option trade, known as a bullish combination, will mimic a long position in the stock and appeared after ALKS bounced off its 200-day moving average. The strategy will double the investor's money for every $0.25 that the stock trades over $12.75 and lose money below $10.

The company is scheduled to make a presentation at the Bank of America Merrill Lynch Small and Mid-Cap Conference at 2:30 p.m. ET today and at the Jefferies Global Life Sciences Conference at 4:30 p.m. ET tomorrow.

Overall options volume in ALKS is 30 times greater than average so far today.

 

(Chart courtesy of tradeMONSTER )

 



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright © 2010 OptionMonster® Holdings, Inc. All Rights Reserved.


This article appears in: Investing , Options

Referenced Stocks: ALKS

optionMONSTER

optionMONSTER

More from optionMONSTER:

Related Videos

Stocks

Referenced

100%

Most Active by Volume

60,251,627
  • $14.905 ▼ 2.26%
29,539,214
  • $94.23 ▼ 0.83%
26,711,675
    $38.29 unch
26,103,631
  • $3.34 ▼ 1.18%
24,088,734
  • $95.50 ▼ 0.10%
22,693,516
  • $71.71 ▼ 1.29%
21,439,776
  • $3.955 ▲ 1.15%
18,902,226
  • $25.1595 ▲ 0.04%
As of 8/1/2014, 12:15 PM